---
layout: default
title: Remdesivir
description: "Remdesivir çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 6 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 146
evidence_level: L5
indication_count: 6
---

# Remdesivir

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>6</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Remdesivirï¼šå¾ COVID-19 åˆ°å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Remdesivir å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Remdesivir æ˜¯ä¸€ç¨®æŠ—ç—…æ¯’è—¥ç‰©ï¼ŒåŸæœ¬ç”¨æ–¼ COVID-19 çš„æ²»ç™‚ã€‚TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å°**å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤ (Multiple Endocrine Neoplasia)** æœ‰æ•ˆï¼Œä½†ç›®å‰**ç„¡è‡¨åºŠè©¦é©—æˆ–æ–‡ç»**ç›´æ¥æ”¯æŒé€™å€‹ç‰¹å®šé©æ‡‰ç—‡ã€‚
</p>


## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | æ–°å‹å† ç‹€ç—…æ¯’ç–¾ç—…ï¼ˆCOVID-19ï¼‰ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | multiple endocrine neoplasiaã€HIV infectious diseaseã€feline acquired immunodeficiency syndromeã€simian immunodeficiency virus infectionã€neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matterã€homozygous familial hypercholesterolemia |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.50% |
| è­‰æ“šç­‰ç´š | L5 |
| å°ç£ä¸Šå¸‚ | å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | å¤šå¼µ |
| å»ºè­°æ±ºç­– | Hold |


## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. multiple endocrine neoplasia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.50%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

### ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ

Remdesivir æ˜¯ä¸€ç¨®æ ¸è‹·é¡ä¼¼ç‰©å‰è—¥ï¼Œèƒ½å¤ æŠ‘åˆ¶ç—…æ¯’çš„ RNA ä¾è³´æ€§ RNA èšåˆé…¶ï¼ˆRdRpï¼‰ï¼Œå¾è€Œé˜»æ­¢ç—…æ¯’è¤‡è£½ã€‚å®ƒæœ€åˆæ˜¯ç‚ºäº†æ²»ç™‚ä¼Šæ³¢æ‹‰ç—…æ¯’æ„ŸæŸ“è€Œé–‹ç™¼ï¼Œå¾Œä¾†å›  COVID-19 ç–«æƒ…è€Œç²å¾—ç·Šæ€¥ä½¿ç”¨æˆæ¬Šã€‚

å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤æ˜¯ä¸€çµ„éºå‚³æ€§ç–¾ç—…ï¼Œç‰¹å¾µæ˜¯å¤šå€‹å…§åˆ†æ³Œè…ºé«”ç™¼ç”Ÿè…«ç˜¤ã€‚é€™æ˜¯ä¸€ç¨®è…«ç˜¤æ€§ç–¾ç—…ï¼Œèˆ‡ç—…æ¯’æ„ŸæŸ“ç„¡é—œã€‚

ç›®å‰å°šä¸æ¸…æ¥š TxGNN æ¨¡å‹ç‚ºä½•é æ¸¬ remdesivir å°å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤æœ‰æ•ˆã€‚å¯èƒ½çš„å‡è¨­åŒ…æ‹¬ï¼š
- çŸ¥è­˜åœ–è­œä¸­çš„é€£çµå¯èƒ½åæ˜ äº†æŸäº›å…±åŒçš„åˆ†å­é€”å¾‘
- æ ¸è‹·é¡ä¼¼ç‰©å¯èƒ½å°å¿«é€Ÿåˆ†è£‚çš„è…«ç˜¤ç´°èƒæœ‰æŸç¨®ä½œç”¨

ç„¶è€Œï¼Œé€™äº›å‡è¨­ç´”å±¬æ¨æ¸¬ï¼Œç¼ºä¹ä»»ä½•ç§‘å­¸è­‰æ“šæ”¯æŒã€‚

### è‡¨åºŠè©¦é©—

ç›®å‰ç„¡ç›¸é—œè‡¨åºŠè©¦é©—ç™»è¨˜ï¼ˆèˆ‡å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤ç›¸é—œï¼‰ã€‚

ç¾æœ‰çš„ remdesivir è‡¨åºŠè©¦é©—ä¸»è¦é‡å° COVID-19 å’Œ HIV æ„ŸæŸ“ï¼š
- å¤šé … COVID-19 ç›¸é—œ Phase 2/3 è©¦é©—å·²å®Œæˆ
- NCT02818582ï¼šä¼Šæ³¢æ‹‰ç—…æ¯’å­˜æ´»è€…çš„ Phase 2 è©¦é©—

### ç›¸é—œæ–‡ç»

ç›®å‰ç„¡ç›¸é—œæ–‡ç»æ”¯æŒ remdesivir ç”¨æ–¼å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤ã€‚

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. HIV infectious disease</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.32%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.32%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. feline acquired immunodeficiency syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.07%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.07%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. simian immunodeficiency virus infection</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.07%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.07%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.03%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.03%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. homozygous familial hypercholesterolemia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.03%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.03%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬XXXXXXè™Ÿ | éŸ‹å¦‚æ„æ³¨å°„ç”¨æº¶æ¶²åŠ‘100æ¯«å…‹/20æ¯«å‡ | æ³¨å°„åŠ‘ | é‡åº¦æ–°å‹å† ç‹€ç—…æ¯’æ„ŸæŸ“ç—‡ |

## å®‰å…¨æ€§è€ƒé‡

å®‰å…¨æ€§è³‡è¨Šè«‹åƒè€ƒåŸå» ä»¿å–®ã€‚

ä¸»è¦æ³¨æ„äº‹é …ï¼š
- è‚åŠŸèƒ½ç•°å¸¸
- è…åŠŸèƒ½æå®³æ‚£è€…éœ€è¬¹æ…ä½¿ç”¨
- è¼¸æ³¨ç›¸é—œåæ‡‰

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**é…’ç²¾ (alcohol)** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šConcomitant use of remdesivir with other agents that are known to induce hepatotoxicity may theoretically increase the risk of liver injury.  Data from investigational use and clinical studies suggest...
- å»ºè­°ï¼šUntil more information is available, concomitant use of remdesivir with known hepatotoxic drugs should be avoided when possible.  Liver function should be evaluated prior to starting remdesivir and mo...



### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**è‚è‡Ÿç–¾ç—… (Liver Diseases)** ğŸŸ¡ Moderate
- Pharmacokinetics of remdesivir have not been evaluated in patients with liver dysfunction.  Hepatic laboratory testing should be performed in all patients before starting this drug and during therapy as clinically appropriate.  Caution is recommended...

**è…è‡Ÿç–¾ç—… (Kidney Diseases)** ğŸŸ¢ Minor
- Pharmacokinetics of remdesivir have not been evaluated in patients with renal dysfunction.  All patients must have estimated glomerular filtration rate (eGFR) determined before starting this drug and during therapy as clinically appropriate.  The exc...

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šHold**

**ç†ç”±ï¼š**
é€™å€‹é æ¸¬ç¼ºä¹ä»»ä½•ç”Ÿç‰©å­¸åˆç†æ€§ã€‚Remdesivir æ˜¯ä¸€ç¨®å°ˆé–€é‡å°ç—…æ¯’ RNA èšåˆé…¶çš„æŠ—ç—…æ¯’è—¥ç‰©ï¼Œè€Œå¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤æ˜¯ä¸€ç¨®éºå‚³æ€§è…«ç˜¤ç–¾ç—…ï¼Œå…©è€…åœ¨ç—…ç†æ©Ÿè½‰ä¸Šæ²’æœ‰æ˜é¡¯é—œè¯ã€‚åœ¨æ²’æœ‰ä»»ä½•åŸºç¤ç ”ç©¶æˆ–è‡¨åºŠè­‰æ“šçš„æƒ…æ³ä¸‹ï¼Œä¸å»ºè­°å°‡æ­¤é æ¸¬æ¨é€²åˆ°è‡¨åºŠæ‡‰ç”¨ã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- æ¢è¨ TxGNN æ¨¡å‹ç”¢ç”Ÿæ­¤é æ¸¬çš„å…·é«”åŸå› 
- é€²è¡ŒåŸºç¤ç ”ç©¶ç¢ºèªæ˜¯å¦å­˜åœ¨ä»»ä½•æ½›åœ¨çš„åˆ†å­æ©Ÿè½‰
- è‹¥æœ‰ä»»ä½•ç†è«–ä¾æ“šï¼Œéœ€é€²è¡Œå‰è‡¨åºŠç ”ç©¶é©—è­‰


---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Diosmin]({{ "/drugs/diosmin/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Nebivolol]({{ "/drugs/nebivolol/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Cladribine]({{ "/drugs/cladribine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Alirocumab]({{ "/drugs/alirocumab/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Levamisole]({{ "/drugs/levamisole/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Remdesivirè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/remdesivir/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_remdesivir,
  title = {Remdesivirè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/remdesivir/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
